RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 1,057 filers reported holding RAYTHEON CO in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.4%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $329,000 | +11.9% | 1,496 | 0.0% | 0.17% | +7.1% |
| Q3 2019 | $294,000 | +13.1% | 1,496 | 0.0% | 0.16% | +13.0% |
| Q2 2019 | $260,000 | -4.4% | 1,496 | 0.0% | 0.14% | -5.5% |
| Q1 2019 | $272,000 | +11.0% | 1,496 | -6.3% | 0.15% | +4.3% |
| Q4 2018 | $245,000 | -25.8% | 1,596 | 0.0% | 0.14% | -11.9% |
| Q3 2018 | $330,000 | +7.1% | 1,596 | 0.0% | 0.16% | +0.6% |
| Q2 2018 | $308,000 | -18.3% | 1,596 | -8.6% | 0.16% | -19.8% |
| Q1 2018 | $377,000 | +14.9% | 1,746 | 0.0% | 0.20% | +19.4% |
| Q4 2017 | $328,000 | -10.1% | 1,746 | -10.7% | 0.16% | -12.2% |
| Q3 2017 | $365,000 | +4.9% | 1,956 | -9.3% | 0.19% | +1.1% |
| Q2 2017 | $348,000 | +5.8% | 2,156 | 0.0% | 0.19% | +5.7% |
| Q1 2017 | $329,000 | +7.5% | 2,156 | 0.0% | 0.18% | +2.3% |
| Q4 2016 | $306,000 | +4.4% | 2,156 | 0.0% | 0.17% | +1.8% |
| Q3 2016 | $293,000 | 0.0% | 2,156 | 0.0% | 0.17% | 0.0% |
| Q2 2016 | $293,000 | -2.7% | 2,156 | -12.2% | 0.17% | -6.6% |
| Q1 2016 | $301,000 | -1.6% | 2,456 | 0.0% | 0.18% | -4.7% |
| Q4 2015 | $306,000 | +14.2% | 2,456 | 0.0% | 0.19% | +9.2% |
| Q3 2015 | $268,000 | 0.0% | 2,456 | 0.0% | 0.17% | +10.8% |
| Q2 2015 | $268,000 | 0.0% | 2,456 | 0.0% | 0.16% | +4.7% |
| Q1 2015 | $268,000 | +0.8% | 2,456 | 0.0% | 0.15% | +3.4% |
| Q4 2014 | $266,000 | +20.4% | 2,456 | +2.5% | 0.14% | +22.9% |
| Q2 2014 | $221,000 | -6.8% | 2,395 | 0.0% | 0.12% | -12.6% |
| Q1 2014 | $237,000 | +0.9% | 2,395 | -7.7% | 0.14% | -1.5% |
| Q4 2013 | $235,000 | -99.9% | 2,595 | 0.0% | 0.14% | +5.4% |
| Q3 2013 | $199,997,000 | – | 2,595 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
| Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
| PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
| Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |